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(57) ABSTRACT 
The invention provides highly functionalised spiro-fused lac 
tams of en formula (I) having a cyclohexane moiety With the 
desired number of protected or un-protected functional 
groups or carbonated structures, Which are introduced With 
high stereo and regioselectivity, as Well as processes for their 
obtention. These compounds are useful for the synthesis of 
abroad range of bioactive molecules, such as condoritols and 
aminoinositols and their analogues. 
(1) 
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REGIOSELECTIVE FUNCTIONALISATION 
AND PROTECTION OF SPIROLACTAMS 
FIELD OF THE INVENTION 
[0001] The present invention relates to neW regioselec 
tively hydroxylated, protected and functionaliZed spirolac 
tams and to processes for their synthesis. 
BACKGROUND OF THE INVENTION 
[0002] Lactams are compounds of high interest due to their 
biological activities, for example Well knoWn [3-lactams such 
as some penicillins, cephalosporins and carbapenems have 
antibacterial activity. 
[0003] Spirolactams are one particular class of lactams that 
have shoWn interesting biological properties. Some spiro 
fused aZetidinones have been described as having antibacte 
rial activity, see US. Pat. No. 4,680,388, or hypocholester 
olemic properties, see for example W0 94 17038. 
Additionally, if these compounds have the adequate function 
ality they are valuable intermediates toWards different fami 
lies of compounds. The spirolactam ring is the equivalent of 
an alpha amino or hydroxy aminoacid and opens many pos 
sibilities in diastero and/or enantioselective synthesis. 
[0004] MiyaZaWa, E. et al. in Helerocycles, vol 59, 1:149 
l60 “Synthesis of spiro-fused nitrogen heterocyclic com 
pounds via N-methoxy-N-acylnitrenium ions using phenylio 
dine (III) bis(tri?uoroacetate) in tri?uoroethanol” describe a 
process to obtain functionalised spirolactams including some 
spirodienones. 
[0005] KukugaWa,Y e al. in]. Org. Chem. 2003, vol. 68, 
6739-6744 “Intramolecular cycliZation With nitrenium ions 
generated by treatment of N-acylaminophthalimides With 
hypervalent iodine compounds: formation of lactams and 
spirofused lactams” describes the formation of functionalised 
spirolactams having diene and dienone funcionalities. 
[0006] The conduritols, aminoconduritols, aminoinositols 
and their derivatives also possess interesting biological prop 
er‘ties, some of them have been shoWn as being antitumoral 
and antibiotic. Although some synthetic processes exist for 
these compounds (See Yong-Uk KWon et al, .1. Org. Chem. 
2002, v1. 67, 3327-3338 “Facile syntheses of all possible 
diastereomers of conduritol and various derivatives of inosi 
tol stereoisomers in high enantiopurity from inyo-inositol”), 
there are still dif?culties to obtain these compounds or corre 
sponding analogues. 
[0007] As it is apparent from the above, any e?icient pro 
cess for producing functionalised spirolactam compounds in 
high yield, With various functionalities, introduced in a con 
trolled and regioselective manner, Would be a Welcome con 
tribution to the art and Will open the door to a variety of 
biologically active compounds. 
SUMMARY OF THE INVENTION 
[0008] Starting from the compounds described in our appli 
cations EP 04380l04.2, EP04076477.1, and PCT/EP2005/ . . 
. (?led the same day as the present application), We found a 
basic set of processes that alloWs the controlled production of 
very stable, highly functionalised, spiro-fused lactames 
Which are useful as intermediate compounds in the prepara 
tion of a variety of chemical structures, including, if neces 
sary, by means of chimio-, loco-, regio-, diastero- and/or 
enantioselective processes. Additional carbon structures can 
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be incorporated at the desired positions by means of simple 
reactions, generating neW intermediates of interest. 
[0009] In one aspect the invention provides a compound of 
formula I: 
formula I 
R5 R6 
R3 R2 
R4 R1 
Z N W 
Y \Y / 
0 
wherein R1, R2, R3 and R4 are each independently selected 
from H, OH, halo, OPR, :O, cyano, substituted or unsubsti 
tuted alkyl, substituted or unsubstituted aryl, substituted or 
unsubstituted heterocyclyl, substituted or unsubstituted 
alkoxy, substituted or unsubstituted aryloxy, substituted or 
unsubstituted amino or halogen, 
[0010] R5 and R6 together are :0 or 4Oi(CH2)mi, 
Wherein m is selected from 1, 2, 3, 4 or 5; or R5 is selected 
from H, OH, OPR and R6 is selected from hydrogen, cyano, 
substituted or unsubstituted alkyl, substituted or unsubsti 
tuted cycloalkyl, substituted or unsubstituted alkenyl, substi 
tuted or unsubstituted alkinyl, substituted or unsubstituted 
aryl, substituted or unsubstituted heterocyclyl, 
With the proviso that at least one of R1, R2, R3, R4 or R5 is OH, 
substituted or unsubstituted alkoxy, substituted or unsubsti 
tuted aryloxy or OPR; 
[0011] PR is an hydroxyl protecting group that can be the 
same or different on each of R1, R2, R3, R4 or R5 and that can 
simultaneously protect l, 2 or 3 hydroxy groups; 
the dotted line represents a single or double bond, With the 
proviso that When both R1 and R2 or R3 and R4 are H then there 
is a double bond betWeen the tWo C to Which the H are linked; 
[0012] Z is i(CRaRb)ni or 4CH2i(CRaRb)i or 
i(CRaRb)iCH2i or iCH2i(CRaRb)4CH2i, or 
i(CH2)2i(CRaRb)i or i(CRaRb)-(CH2)2i Wherein n 
is a number selected from 1, 2 or 3 and Ra and Rb are each 
independently selected from hydrogen, substituted or unsub 
stituted alkyl, substituted or unsubstituted cycloalkyl, substi 
tuted or unsubstituted alkenyl, substituted or unsubstituted 
aryl, substituted or unsubstituted heterocyclyl, substituted or 
unsubstituted alkoxy, substituted or unsubstituted aryloxy, 
substituted or unsubstituted amino or halogen; 
[0013] Y is selected from 40*, iSi, iNRai or 
4C(O)i, Wherein Ra is as previously de?ned; 
[0014] W is a group comprising at least a group selected 
from substituted or unsubstituted aryl, substituted or usubsti 
tuted heterocyclyl, substituted or unsubstituted alkenyl; or a 
salt, complex or solvate thereof 
[0015] In one embodiment the compounds of the invention 
are as de?ned With the proviso that When Z is iCHZCHZi 
then Y is selected from 40*, iSi, iNRai or 
%(O)i. 
[0016] In one embodiment We prefer that n is 1. In this case 
Z is preferably 4CHRai. 
[0017] In another embodiment W is selected from substi 
tuted or unsubstituted arylalkyl, substituted or unsubstituted 
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heterocyclylalkyl, substituted or unsubstituted alkenyl. More 
preferably it is arylalkyl, preferably benZyl. 
[0018] In a further embodimentY is preferably 40*. 
[0019] The invention also provides for a process for the 
preparation of a compound according of formula I, Which 
comprises in any order one or more of a step selected from the 
group consisting of: 
a) hydroxylation, ketohydroxylation or dihydroxylation 
b) hydroxyl or carbonyl protection 
c) nucleophilic attack at the carbonyl group or double bonds 
d) hydroxyl inversion 
e) allylic rearrangements 
applied to a compound of formula IV: 
formula IV 
Wherein Z, Y and W are as de?ned above. 
DETAILED DESCRIPTION OF THE INVENTION 
[0020] In this description the folloWing numbering Will be 
used: 
7 
8 6 
9 5 
1 \g' 
R—N Z3 
if 
O 
[0021] In one aspect the invention provides compounds of 
formula I as above de?ned. In the compounds of formula I, the 
group Z gives rise to a ring of 4, 5 or 6 members. 
[0022] Although rings of 5 or 6 are also comprised Within 
the scope of the invention, in one embodiment the [3-lactam 
ring (n:l) is preferred because of the further uses that can be 
given to such compounds. 
[0023] Substitution on position Z creates a stereogenic cen 
ter that could induce selective functionalisation on the ben 
Zodienone moiety. In a preferred embodiment Z has a chiral 
center. Especially preferred is 4CHRai With Ra not being 
H, in these cases the stereogenic center in the [3-lactam ring 
alloWs for the selectivity or speci?city of any further reaction. 
More preferably Ra is an halo, hydroxy, alkoxy, aryloxy 
group or an hydroxy protected group. 
[0024] The group Y in the compounds of formula I plays a 
role in the stability and conformation. In an embodimentY is 
preferably iOi, although other atoms are not excluded as 
long as the ?nal product is stable. 
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[0025] The W group is important for the stabiliZation of the 
compounds of formula I. It comprises unsaturated bonds or 
aromatic groups to increase the p interaction betWeen W and 
the double bonds or hydrogens. 
[0026] Preferably W is selected from substituted or unsub 
stituted arylalkyl, substituted or unsubstituted heterocyclyla 
lkyl, substituted or unsubstituted alkenyl. 
[0027] More preferably it is arylalkyl, preferably benZyl. 
[0028] In a particular embodiment, W is iCRaRb-Q or 
iSiRaRb-Q since the stability of the conformation is further 
improved by the presence of a 4CRaRbi or a iSiRaRbi 
linker betWeen Y and the substituent Q Which has p (pi) 
interactions With the benZodienone moiety. The linker is pref 
erably iCHRai. This introduces a chiral center if neces 
sary, and Will advantageously open the Way to diastero- and/ 
or enantioselective synthesis in addition to the selection for 
one face Which is explained beloW. Depending on the siZe of 
Ra it can also modulate the p (pi) interactions. 
[0029] In one embodiment W is an aralkyl group. Among 
the aryl groups substituted or unsubstituted phenyl and naph 
thyl are preferred. Heterocyclylalkyl groups are also envis 
aged. BenZyl is the simplest W subtituent and gives good 
results. Particular embodiments of the compounds of the 
present invention are as folloWs. A compound as de?ned 
above having formula II 
formula II 
R5 R6 
H 0R7 
H 0R8 
Ra N 
\ 
O —W 
0 
wherein R7 and R8 are independently selected from H, sub 
stituted or unsubstituted alkyl or PR; W, Ra, R5 and R6 are as 
de?ned above, or their salts, isomers or solvates. 
[003 0] In another embodiment a compound having formula 
III is preferred, 
formula III 
R5 R6 
R90 0R7 
R100 0R8 
N 
\ 
Ra O—W 
O 
Wherein R7, R8, R9 and R10 are each independently selected 
from H, substituted or unsubstituted alkyl or PR; W, Ra, R5 
and R6 are as de?ned above. Particular embodiments of the 
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invention are compounds that correspond to any of the fol 
lowing formulae: 
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-continued 
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-continued 
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wherein W, PR and Ra are as above de?ned and Wherein the 
protecting groups PR1 -5 can be the same or different and can 
simultaneously protect 2 or 3 different hydroxy groups, and 
Nu is a nucleophilic group; their diastereoisomers, enanti 
omers and mixtures thereof. Representative compounds are 
those having the folloWing relative con?gurations: 
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-c0ntinued -c0ntinued 
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-continued 
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-continued 
oPRl 
[0031] Further embodiments of the compounds of the 
invention are described below and in the examples. It is evi 
dent for the person skilled in the art that many variations and 
con?gurations are possible and can be obtained at Will 
depending on the compounds selected as starting materials, 
the relative con?gurations of the functional groups present, 
the presence or not of chiral centers, and on the combination 
of reactions that are applied. The present invention encom 
passes all such variations and possibilities. 
[0032] In the above de?nition of compounds of formula (I) 
and in the description the folloWing terms have the meaning 
indicated: 
[0033] “Alkyl” refers to a straight or branched hydrocarbon 
chain radical consisting of carbon and hydrogen atoms, con 
taining no saturation, having 1-12, preferably one to eight 
carbon atoms, and Which is attached to the rest of the mol 
ecule by a single bond, e. g., methyl, ethyl, n-propyl, i-propyl, 
n-butyl, t-butyl, n-pentyl, etc. Alkyl radicals may be option 
ally substituted by one or more substituents such as halo, 
hydroxy, alkoxy, carboxy, cyano, carbonyl, acyl, alkoxycar 
bonyl, amino, nitro, mercapto and alkylthio. 
[0034] “Alkoxy” refers to a radical of the formula iORa 
Where Ra is an alkyl radical as de?ned above, e.g., methoxy, 
ethoxy, propoxy, etc. “Aryloxy” refers to a radical of formula 
4ORb Wherein Rb is an aryl radical as de?ned beloW. 
[0035] “Amino” refers to a radical of the formula-NH2, 
iNHRa, iNRaRb. 
[0036] “Aryl” refers to an aromatic hydrocarbon radical 
such as phenyl, naphthyl or anthracyl. The aryl radical may be 
optionally substituted by one or more substituents such as 
hydroxy, mercapto, halo, alkyl, phenyl, alkoxy, haloalkyl, 
nitro, cyano, dialkylamino, aminoalkyl, acyl and alkoxycar 
bonyl, as de?ned herein. 
[0037] “Aralkyl” refers to an aryl group linked to an alkyl 
group such as benZyl and phenethyl. 
[0038] “Cycloalkyl” refers to a saturated carbocyclic ring 
having from 3 to 8 carbon atoms. 
[0039] “Heterocyclyl” refers to a stable 3- to 15-membered 
ring Which consists of carbon atoms and from one to ?ve 
heteroatoms selected from the group consisting of nitrogen, 
oxygen, and sulfur, preferably a 4- to 8-membered ring With 
one or more heteroatoms, more preferably a 5- or 6-mem 
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bered ring With one or more heteroatoms. For the purposes of 
this invention, the heterocycle may be a monocyclic, bicyclic 
or tricyclic ring system, Which may include fused ring sys 
tems; and the nitrogen, carbon or sulfur atoms in the hetero 
cyclyl radical may be optionally oxidised; the nitrogen atom 
may be optionally quaterniZed; and the heterocyclyl radical 
may be partially or fully saturated or aromatic. Examples of 
such heterocycles include, but are not limited to, aZepines, 
benZimidaZole, benZothiaZole, furan, isothiaZole, imidaZole, 
indole, piperidine, piperaZine, purine, quinoline, thiadiaZole, 
tetrahydrofuran. 
[0040] “Hydroxyl protecting group” refers to a group that 
blocks the OH function for further reactions and can be 
removed under controlled conditions. The hydroxyl protect 
ing groups are Well knoWn in the art, representative protecting 
groups are silyl ethers such as trimethylsilyl ether, triethylsi 
lyl ether, tert-butyldimethylsilyl ether, tert-butyldiphenylsilyl 
ether, tri-isopropylsilyl ether, diethylisopropylsilyl ether, 
thexyldimethylsilyl ether, triphenylsilyl ether, di-tert-butyl 
methylsilyl ether; alkyl ethers such as methyl ether, tert-butyl 
ether, benZyl ether, p-methoxybenZyl ether, 3,4-dimethoxy 
benZyl ether, trityl ether; allyl ether; alkoxymethyl ether such 
as methoxymethyl ether, 2-methoxyethoxymethyl ether, ben 
Zyloxymethyl ether, p-methoxybenZyloxymethyl ether, 
2-(trimethylsilyl)ethoxymethyl ether; tetrahydropyranyl and 
related ethers; methylthiomethyl ether; Esters such as acetate 
ester, benZoate ester; pivalate ester; methoxyacetate ester; 
chloroacetate ester; levulinate ester; Carbonates such as ben 
Zyl carbonate, p-nitrobenZyl carbonate, tert-butyl carbonate, 
2,2,2-trichloroethyl carbonate, 2-(trimethylsilyl)ethyl car 
bonate, allyl carbonate; and sulphates such as SO3.py. Addi 
tional examples of hydroxyl protecting groups can be found 
in reference books such as Greene and Wuts’ “Protective 
Groups in Organic Synthesis”, John Wiley & Sons, Inc., NeW 
York, 1999. References herein to substituted groups in the 
compounds of the present invention refer to the speci?ed 
moiety that may be substituted at one or more available posi 
tions by one or more suitable groups, e.g., halogen such as 
?uoro, chloro, bromo and iodo; cyano; hydroxyl; nitro; aZido; 
alkanoyl such as a C1_6 alkanoyl group such as acyl and the 
like; carboxamido; alkyl groups including those groups hav 
ing 1 to about 12 carbon atoms or from 1 to about 6 carbon 
atoms and more preferably l-3 carbon atoms; alkenyl and 
alkynyl groups including groups having one or more unsat 
urated linkages and from 2 to about 12 carbon or from 2 to 
about 6 carbon atoms; alkoxy groups having one or more 
oxygen linkages and from 1 to about 12 carbon atoms or I to 
about 6 carbon atoms aryloxy such as phenoxy; alkylthio 
groups including those moieties having one or more thioether 
linkages and from 1 to about 12 carbon atoms or from 1 to 
about 6 carbon atoms; alkylsul?nyl groups including those 
moieties having one or more sul?nyl linkages and from 1 to 
about 12 carbon atoms or from 1 to about 6 carbon atoms; 
alkylsulfonyl groups including those moieties having one or 
more sulfonyl linkages and from 1 to about 12 carbon atoms 
or from 1 to about 6 carbon atoms; aminoalkyl groups such as 
groups having one or more N atoms and from 1 to about 12 
carbon atoms or from 1 to about 6 carbon atoms; carbocylic 
aryl having 6 or more carbons, particularly phenyl or naphthyl 
and aralkyl such as benZyl. Unless otherWise indicated, an 
optionally substituted group may have a substituent at each 
substitutable position of the group, and each substitution is 
independent of the other. 
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[0041] The compounds of the invention can be prepared 
using a basic set of simple reactions that alloW the protection, 
functionalisation of the different positions in a very ste 
reospeci?c manner. These procedures Will be explained 
beloW. In the folloWing note that the con?gurations given are 
only relative con?gurations and not that of the pure enanti 
omers. To proceed With enantioselectivity, either a chiral 
center such as in Z or W is needed, or the use of chiral 
reagents. 
[0042] In our applications EP04380104.2, and PCT/ 
EP2005/ . . . (?led the same day as the present application), 
Which are incorporated herein by reference in their entirety, 
We describe neW compounds having a formula IV and pro 
cesses for their obtention: 
formula IV 
0 
Z N W 
Y \Y/ 
0 
wherein Z, W andY are as above de?ned and W is a group 
With suf?cient electronic density to stabiliZe the compound 
through p (pi) interactions With the benZodienone moiety, 
preferably a group having unsaturated bonds or aromatic 
groups, more preferably it is selected from substituted or 
unsubstituted arylalkyl, substituted or unsubstituted hetero 
cyclylalkyl, or substituted or unsubstituted alkenyl. 
[0043] These compounds are remarkably stable due to p 
interactions betWeen the W group and the benZodienone moi 
ety. Additionally these compounds adopt a preferential con 
formation in Which the W group blocks one of the faces of the 
benZodienone (hereinafter the [3 face) and is “?xed” there by 
the p interactions, directing further reactions to the free face 
of the benZodienone moeity (hereinafter the a face). 
[0044] 
ing from these compounds it is possible to regioselectively 
hydroxylate, functionalise and protect the different positions 
Taking advantage of this, We have found that start 
of the benZodienone group, to give a broad range of stable 
compounds having the desired functionality and protection at 
each of the 5 available positions. of the cyclohexadienone 
moiety. Further, carbonated sub stituents can be introduced on 
the obtained compounds, to generate a neW carbon skeleton at 
Wish. All these highly functionalised compounds are useful as 
building blocks for a Wide variety of bioactive compounds. 
[0045] If only one hydroxy group is desired, it can be intro 
duced regioselectively for example via formation of the cyan 
hydrine on the carbonyl group, the hydroboration or hydro 
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sililation of one of the double bonds (via the a face), then 
oxidation and ?nal treatment With acid or AgF: 
O TMSO CN 
1.BH3 
TMSCN 2. oxid. 
—> —> 
Z N\ /W Z N\ /W 3.H*AgF 
Y Y Y Y 
o o 
0 
OH 
Z N W 
Y \Y/ 
o 
[0046] Other alternatives procedures are possible. Signi? 
cantly, the hydroxylation takes place via one face of the 
dienone only. The hydroxyl group can then be protected With 
any desired hydroxyl protecting group such as those listed 
above. 
[0047] In another embodiment of the invention We provide 
for the diastereoselective dihydroxylation of one of the 
double bonds of the benZodienone moiety. This is a surprising 
result, in vieW of the expected poor reactivity of the structure 
of formula IV, due to the highly deactivated double bonds. 
Additionally, contrary to What is expected, the dihydroxyla 
tion takes place regioselectively, only via the a face: 
O O 
OH 
—> 
OH 
ZYN\Y/W ZYN\Y/W 
O O 
[0048] This oxidation occurs readily under mild condi 
tions, such as using OsO4 in a polar solvent, for example a 
mixture of Water an ketone, in the presence of an amine such 
as N-methylmorpholine N-oxide. Alternative oxidation sys 
tems Will be readily apparent to the person skilled in the are 
and can be found in standard references for organic synthesis 
such as Noyori, R. “Asymmetric catalysis in organic synthe 
sis”, John Wiley and Sons, Inc. (1994) or Ojima, I. “Catalytic 
asymmetric synthesis VCH, (1993) 
[0049] The dihydroxylated compound can be selectively 
protected. Indeed, When carrying out a protection such as 
With Cl-TBDMS We found that the hydroxyl at position 6 
reacted until being completely protected, and only then the 
OH at position 5 is protected. 
Nov. 13, 2008 
O O 
OH OPr 
—> 
OH OH 
Z N W Z N W 
Y \Y/ Y \Y/ 
O O 
[0050] Without being bound by theory, We believe that this 
is due to the existence of CiH p interactions betWeen the H 
at position 6 and the W group. This means that the ‘OH at 
position 6 is in an equatorial conformation, more reactive, 
While the ‘OH at position 5 is in an axial conformation, less 
reactive. This alloWs the selective reaction of one position 
With respect to the other. 
OH (axial) 
[0051] Therefore, both the facial selection (a versus [3) 
When carrying out the hydroxylation, and the different reac 
tivity of positions 5 and 6, due to the particular conformations 
generated by the presence of the W group and its interactions 
With the rest of the molecule, alloWs for a ?ne tuned control of 
the functionalisation of the molecule. This effect has been 
demonstrated by a very intensive NOE effect betWeen the 
protons of the arylic portion and the protons of the cyclohexa 
diene moiety, and in particular With H at position 6. 
[0052] In some cases the protecting group can migrate from 
position 6 to position 5 for example When the protecting 
group has migrating capacity such as With esters, carbonates, 
silylethers, etc. For example in the case of benZyl: 
O O 
OBn OH 
A 
—> 
<— 
OH OBn 
Z N W Z N W 
Y \Y/ Y \Y/ 
O O 
[0053] At the same time there is a change is the conforma 
tion as Well, the OBn Will be in equatorial position at the C5. 
In this Way We can have one hydroxy or the other protected. 
US 2008/0281094 A1 
[0054] The tWo hydroxy groups can be protected With tWo 
protecting groups being the same as explained above, or With 
different protecting groups, ?rst protecting the position 6 and 
then the position 5: 
O O 
OPT] OPT] 
PI‘Z 
—> 
OH OPrZ 
Z N W Z N W 
Y \Y/ Y \Y/ 
O O 
[0055] To introduce the hydroxyl protecting groups stan 
dard procedures can be used, such as those described in 
Greene and Wuts’ “Protective Groups in Organic Synthesis”, 
John Wiley & Sons, Inc. NeW York, 1999 or Kocienski, P. J. 
“Protecting Groups”, 3’ Ed. Thieme Chemistry, 2003. 
[0056] In another embodiment the carbonyl group can also 
be selectively functionaliZed for example by Nucleophilic 
addition. Importantly, the lactam group does not react instead 
because it has a Weinreb type of amide. Thus cyanides, orga 
nolithium compounds, Grignard’s reagents, aZides, halogens, 
and ketones among other can be easily added to introduce the 
desired functionality at this position. If an hydride is used 
then an hydroxy at position 3 is generated. Suitable proce 
dures for this kind of reactions are knoWn in the art and can be 
found for example in Fischer, A. et al J. Org. Chem., 1987, 52, 
4464-4468 “Formation of 4-nitrocyclohexa-2,5-dienols by 
addition of organolithium reagents to 4-alkyl-4-nitrocyclo 
hexa-2,5-dione”; Wipf et al., Angew. Chem. Int. Ed. Engl. 
1997, 36, no. 7, 764-767; Fischer, A. et al., Tetrahedron leZL, 
1980, 21, 701-704; Carreno, M. et al., J. Org. Chem., 1997, 
62, 26, 9128-9137, or March, I “Advanced Organic Chemis 
try” 5’h Ed. (2001). 
[0057] The additions can be done independently of the 
functionalisation of the other positions. If no other hydroxy 
groups are present: 
O 
TMSCN 
—> 
Z N W 
Y \Y/ 
O 
[0058] This reaction occurs With no stereoselectivity. The 
compounds can be in any case separated by resolution pro 
cedures knoW in the art, such as chromatography. 
Nov. 13, 2008 
[0059] As an alternative to functionalisation, if desired the 
carbonyl group can be protected using knoW carbonyl pro 
tecting groups. 
[0060] On the other hand, the additions can be done inde 
pendently of the functionalisation of the other positions. We 
have found that When the compound of formula IV is ?rst 
dihydroxylated and then the addition to the carbonyl is carried 
out, complete stereoselectivity is achieved. Although not 
completely clear, it appears that this important stereoselec 
tivity is due to stereoelectronic effects betWeen positions 6 
and 7, and to the above mentioned conformation at position 6. 
For example: 
O 
oPRl 
oPR2 
Z N 
Y \ Y—W 
O 
[0061] One particular example of such a process is the 
folloWing: 
[0062] 
group, the addition and the protection of the second hydroxyl 
group are carried out simultaneously. 
If for example PRZCN is used, being PR a protecting 
[0063] Depending on the Nucleophilic reagent used the 
product of the reaction can have different structures. For 
example, if an epoxide With a de?ned conformation is 
desired, then a reagent such as an S ylide can be used. Under 
conditions of a Corey’s epoxidation only one epoxide is 
obtained [a) E. J. Corey; Michael Chaykovsky J. Am. Chem. 
Soc. 87, 1965, 1353-1364. b) Steven P. Tanis, Mark C. 
McMills, Paul M. Herrinton J. Org. Chem. 50, 1985, 5887 
5889. c) Malcolm Chandler, Richard Conroy, Anthony W. J. 
US 2008/0281094 A1 
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Cooper, R. Brian Lamont, Jan I. Scicinski, James E. Smart, 
Richard Storer, Niall G. Weir, Richard D. Wilson and Paul G. 
Wyatt J. Chem. Soc. Perkin Trans. 1, 1995, 1189-1197]: 
oPRl 
[0064] Alternatively a double bond can be generated, for 
example under Wittig’s conditions. In this case the Nucleo 
phile is a C ylide. 
o 
oPRl OPR1 
_> 
oPR2 OPRZ 
ZYN\Y/W ZYN\Y/W 
o o 
[0065] The double bond can have further substituents at 
position 10 depending on the reagent used. From this struc 
ture, With tWo differentiated double bonds, further reactions 
can be carried out as We Will explain beloW. 
[0066] If the Nucleophile is directed to the double bond 
instead of the carbonyl then the functionality or the additional 
carbon group is added at position 9: 
o 
oPRl 
_> 
Nu oPR2 
ZYN\Y 
O 
oPRl 
oPR2 
Z N W 
Y \Y/ 
O O 
[0067] In such a Way, groups such as cyanide, halogen or an 
allylic group can for example be introduced at position 9, 
opening neW possibilities for further construction. It Will be 
understood that once this Nu is introduced, then the above 
reactions on the carbonyl group, such as another nucleophilic 
attack can be done to generate neW structures. For example, if 
Nov. 13, 2008 
Corey’s epoxidation or Wittig’s reaction are carried out on 
this neW substrate, the folloWing structures can be obtained: 
0 
oPRl OPR1 
_> 
Nu oPR2 
ZYN\Y/W 
o 
[0068] The epoxides can be opened to give an hydroxyl 
group at position 10. This can be done With the simultaneous 
introduction of a Nucleophilic or halogen group at position 9: 
oPR3 
oPRl 
Nu oPR2 
[0069] In this Way We generate a neW double bond betWeen 
positions 7 and 8 Which again opens many possibilities for 
further functionalisation. For example, a simple dihydroxy 
lation Will generate a highly functionalised structure, With 
tWo neW and differentiated hydroxy groups: 
oPR3 
oPRl 
Nu oPR2 
[0070] A further example of a combined protection and 
introduction of halogen folloWing these ideas is: 
C0269, I2 
n-BuLi 
US 2008/0281094 A1 
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The halogen can then be easily exchanged With another 
group: 
P10 P20 
[0071] In another aspect of the invention, the second double 
bond (positions 4 and 5) can also be stereoselectively 
hydroxylated. This occurs more readily When the carbonyl 
group at position 3 is present, We think because it alloWs the 
in situ generation of an allylic alcohol, Which might indicate 
that it plays a role in the oxidation process. Thus, under mild 
conditions: 
0 O 
OPT] H01,’ OPT] 
OsO4 OH Ho“““ OH 
Z N W Z N W 
Y \Y/ Y \Y/ 
O O 
[0072] In this case the hydroxyl groups appear at the B face, 
We believe for stereoelectronic reasons. If a different stere 
ochemistry is desired the appropriate oxidation or epimeriZa 
tion conditions can be selected. For example, under selective 
acidic or basic conditions the hydroxy at position 4 epimer 
iZes. Alternatively hydroxyl inversions via the Mitsunobu 
type reaction, such as using DEAD, Ph3P and an acid such as 
benZoic or p-nitrobenZoic acid, can be used. Frequently, the 
inversion via Mitsunobu needs protection of the other 
hydroxyl groups. Further details on the inversion via the 
Mitsunobu reaction can be found in Mitsunobu, O., Synthesis, 
1, 1981; or Hughes, D. L., Org Reactions, 1992, 42, 335. 
Nov. 13, 2008 
[0073] The dihydroxylation can be carried out on the prod 
uct of Wittig’s reaction, in this case tWo differentiated 
hydroxy groups are introduced at positions 7 and 10: 
oPRl 
—> 
oPR2 
Z N 
\ 
Y—W 
o 
[0074] 
With, for example, a peroxide under mild conditions, We 
If instead of a dihydroxylation We do an epoxidation 
obtain an epoxide With just the opposite con?guration at 7 
When compared With the epoxide obtained directly under 
Corey’s conditions: 
oPRl 
[0075] Thus, even through all these reactions We are still 
able to control the stereochemistry at the different positions. 
This alloWs us to prepare intermediates With the adequate 
con?guration in order to reach doWnstream the different ste 
reoisomers of biologically active compounds. 
[0076] A further example of oxidation reaction is the epoxi 
dation of the double bond betWeen positions 8 and 9. Depend 
ing on the oxidation system used and the protecting groups 
present the epoxidation can give one con?guration or another: 
0 O 
OPRl OPRI 
—> 0 
OPR; OPRz 
Z N W Z N 
K \Y/ K \Y_W 
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[0077] Below are some examples of this kind of reaction: 
VO(acac)2, 
tBuOOH 
Benzene 
VO(acac)2, 
‘BuOOH, CHZCIZ, 
Molecular sleve 
US 2008/0281094 Al 
13 
[0078] Further, these compounds can be selectively depro 
tected, the protecting groups exchanged or the epoxide can be 
opened With a Nucleophilic group or With an halogen. For 
example: 
HO 
Nov. 13, 2008 
O 
Ph)]\Cl 
DMAP, py 
cnzcl2 
/\ 
V(acac)2 Ph OH 
TBHP C1103]: 4)2 
CHZCIZ cnzcl2 
O 
PhiO TBDMSO 
\\ \\ H 
" OTBDMS “ OTBDMS 
0))“ 0))“ EtzAlCN 1M 
¢~ OTMS ‘e. OTMS Tolueno 
O — N O — N 
Ph J Ph J 
O O 
[0079] Of course, from the starting compound of formula [0080] When carrying out oxidations, if the carbonyl group 
IV a double epoxidation can take place: 
0 o 
o 0 CF Oxid. —> 
z N W z N \Y/ \ 
Y—W 
o 0 
has already been functionaliZed, then stronger oxidation con 
ditions are needed, such as the use of RuCl3 or similar sys 
tems: 
Pr3O Nu Pr3O Nu 
" OPrl H00,’ " OPrl 
Ox. ‘. 
—> \\\“ + 
OPrZ HO OPrZ 
US 2008/0281094 A1 
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[0081] 
agent used or conditions of the reaction an overoxidation can 
In this case depending on the amount of oxidating 
occur, leading to the creation of a neW carbonyl at position 8, 
in good yields, Which opens the Way to neW possibilities. The 
carbonyl is generated at this position because is thermody 
namically more stable. Both compounds are easily separated 
With Well knoWn procedures. 
C) + G) + Q) 
12% 18% 3% 
Oxone 
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[0082] The conditions of dihydroxylation or ketohydroxy 
lation can be controled. If less oxidating agent is used only the 
dihydroxycompound is obtained: 
Pr3O liu Pr3O hlu 
H00,’ ’ OPrl 
Ho““ OPrZ 
Z N W 
Y \O/ 
o 
’ OPrl 
OX. 
OPrZ —> 
Z N W 
Y \O/ 
Further information on the reagents and conditions for the 
ketohydroxylation reactions can be found, for example, in 
Plietker, B. J. Org. Chem. 2003, 68, 7123-7125 and J. Org. 
Chem. xxx “The RuO4-catalyZed ketohydroxylation. Part 1. 
Development, Scope and Limitation” Whch are incorporated 
herein by reference in their entirety. 
[0083] If a carbon (10) is present at position 7 then the 
carbonyl can be generated at position 9 instead. The balance 
of products obtained Will be probably due to the en-diol 
equilibrium that gives rise to the thermodinamically more 
stable compounds: 
US 2008/0281094 A1 
PCC 
Celita 
[0084] 
tional procedures. Through this processes We introduce the 
carbonyl group at positions 8 or 9 as an altenative to position 
7. 
These compounds are easily separated by conven 
Complete orthogonal and complete regioselective protection 
can be achieved from here by introduction of a further pro 
tecting group: 
Nu Pr3O Nu Pr3O 
HO,” OPrl Pr4O,,lI " OPrl 
PR4 ,‘ \\‘ —> \\“‘ 
HO OPrZ HO OPrZ 
Z N W Z N W 
[0085] The presence of vicinal hydroxyl groups alloWs the 
simultaneous protection of tWo of them through the use of 
diol protecting groups if desired. Among the diol protecting 
groups that can be used We have 0,0-acetals such as isopro 
pylidene acetals (acetonides); cyclohexylidene and cyclopen 
tylidene acetals; arylmethylene acetals; methylene acetals; 
diphenylmethylene acetals; 1,2-diacetals such as dispiroketal 
(dispoke) derivatives, cyclohexane-l ,2-diacetals, butane-2,3 
diacetals; silylene derivatives; 1,1,3,3-tetraisopropyldisi 
loxanylidene derivatives or N,O-acetals. Additional 
examples of diol protecting groups can be found in reference 
books such as Greene and Wuts’ “Protective Groups in 
Organic Synthesis”, John Wiley & Sons, Inc., NeW York, 
1999. Additionally, borolanes can be formed on the tWo vici 
nal hydroxy groups, for example using phenylboric acid. 
[0086] One example of such a compound With vicinal pro 
tection is: 
-continued 
TBDMSO 
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[0087] In this case the 7 member ring accommodates the 
axial-equatorial position of the tWo OH being protected. 
[0088] As an alternative, dihydroxylation and protection 
can be carried out simultaneously: 
oPRl 
oPR2 
O 
[0089] Or, if desired, only one of the hydroxy groups can be 
selectively protected due to their different nature (primary 
versus tertiary alcohol): 
US 2008/0281094 Al 
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[0090] Depending on the protecting group used the stere 
ochemistry of the second dihydroxylation can be controlled. 
For example: 
HO 
\\\\OH “ O\si 
\ EOMCl 
iPrEtN 
\\\\OH\<>/ 
" O\si 
\O RuCl3 
N 10 / —>a ‘‘ 
/Si 
TBDMSCl 
—> 
Nov. 13, 2008 
-continued 
[0091] Thus to avoid that the second dihydroxylation or 
ketohydroxylation depends on thermodynamical factors, ste 
reoselectivity can be controlled chemically instead using the 
appropriate protecting groups. Conformation plays an impor 
tant role in these reactions. For example: 
US 2008/0281094 A1 
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[0092] The use of protecting groups of a certain size, or that 
are linked simultaneously to tWo different positions can there 
fore control the stereochemistry of the product. 
[0093] Further, a carbolactone can be produced through 
reaction of a functionalised Nucleophile at the carbonyl 
group and lactoniZation With the unprotected hydroxyl group 
Which is present at position 8, for example using methyl 
(triphenylphosphoranylidene)acetate: 
O 
HO/,, oPRl 
I —> 
Ho““ oPR2 
Z N W 
Y \Y/ 
O 
r, un er s ron er con i ions: 0094 0 d t g dt 
0 
HO,“ oPRl 
—> 
no“ oPR2 
Z N 
\ 
Y—W 
O 
Again, We obtain a neW structure plenty of functionalities 
With can be further subjected to additional reactions. 
[0095] 
mation of an orthoester. This provides for a very precise 
conformational control and the simultaneous protection of 3 
An alternative system of protection involves the for 
hydroxy groups. Under adequate conditions the orthoester is 
formed starting form an ester protected hydroxy group. Fur 
ther information on the conditions needed can be found for 
example in Giner J L et al. J. Org. Chem. 2002, 67:2717-2720 
“A biomimetic approach to the synthesis of an antiviral 
marine steroidal orthoester” and references therein, Which is 
incorporated by reference in its entirety. Thus structures of 
the folloWing type, stabiliZed through an hydrogen bond, are 
easily accessible: 
R o 
yl Z O 
o o \o \f 
| T 
Y\ 
o o W 
H/ \H/ 
An example of a route to these compounds is: 
Nov. 13, 2008 US 2008/0281094 A1 
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SONEO “aim; 8339 
0 
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[0096] As We already mentioned, allylic rearrangements [0098] This strategy provides stereospeci?c accessto struc 
can be advantageously used to shift and introduce function- tures of the type? 
alities at the desired positions, for example following the 0H3 0H3 
scheme: 
OPrl oPRl 
Ho““ OPrZ Ho““ OPrZ 
/ \ §|(—N\\ Z §|(—N° Z 
OR OR OR W Y W Y 
O O 
HO OPr3 
/ / 
—> —> OPT] 
HO 0 R 
c, OPrZ 
T” 
[0097] If the hydroxyl group is protected, then under appro- W Y 
priate conditions the 4CH2OR group or any other at this 0 
position can migrate instead. [0099] Example of such rearrangements are the folloWing: 
iPrZEtN 
DMAP 
RuCl3 
Nmo4 Reo3(osiPh3),/ 
[0100] The folloWing scheme shoWs more examples of the 
possibilities open using the basic set of reactions already 
described, With stereospeci?c control of the groups intro 
duced. In this case Z is 4CH2i, but it can be any of the 
above de?ned, in particular Z can have a chiral centre. In this 
case enantiospeci?c reactions Will be possible. 

























